Biomarkers and Endophenotypes of Post-traumatic Headaches

Area of Science:

• Neurology
• Neuroscience
• Biochemistry

Background:

• Post-traumatic headache (PTH) is a common sequela of traumatic brain injury (TBI).
• The underlying pathophysiology involves neurochemical changes and activation of pain pathways.
• Understanding biomarkers is crucial for diagnosis and management of PTH.

Purpose of the Study:

• To conduct a literature review on existing biomarkers for post-traumatic headache (PTH).
• To identify potential molecular targets implicated in PTH pathophysiology.

Main Methods:

• Systematic review of preclinical and clinical studies.
• Analysis of literature on neuropeptides and growth factors in relation to PTH.
• Evaluation of identified studies on specific biomarkers like CGRP and NGF.

Main Results:

• TBI induces ionic flux, glutamatergic surge, and trigeminal nerve activation, releasing pain neuropeptides.
• Calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are key in migraine pathophysiology.
• Limited studies show no consistent CGRP levels in PTH; one study found elevated nerve growth factor (NGF).

Conclusions:

• Currently, there is no conclusive evidence for reliable blood-based biomarkers for PTH.
• Assay limitations, collection techniques, and timing post-injury are significant challenges.
• Further research is needed to explore multiple potential biomarker candidates.